Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

33.87
Delayed Data
As of 4:00pm ET
 +0.55 / +1.65%
Today’s Change
28.25
Today|||52-Week Range
37.39
+4.93%
Year-to-Date
US Market Indexes Gain on Friday
6:24pm / GuruFocus News - Paid Partner Content
This Hated Pharma Stock Has A Bright Future
Sep 26 / StreetAuthority - Paid Partner Content
3 Top Healthcare Stocks to Buy Now
2:47pm / MotleyFool.com - Paid Partner Content
Carnival dragged down by cruise line gloom
Sep 26 / FT.com - Paid Partner Content
ARIAD (ARIA) Leukemia Drug Iclusig Gets Approval in Japan
10:54am / Zacks.com - Paid Partner Content
Read Scraps Pfizer Break-up As Megadeals Escape Its Grasp
Sep 26 / TheStreet.com - Paid Partner Content
England's chief medic says NHS should fund drug to prevent HIV
7:30am / FT.com - Paid Partner Content
Pfizer drops plans to split into essential and innovative units
Sep 26 / FT.com - Paid Partner Content
Deutsche Bank's Losses Affecting the Market on Thursday
Sep 29 / GuruFocus News - Paid Partner Content
Pfizer (PFE) Stock Declines, Bernstein: More Deals Seem Likely
Sep 26 / TheStreet.com - Paid Partner Content
Why Exelixis, Inc. Continued Its Downfall Today
Sep 29 / MotleyFool.com - Paid Partner Content
Stocks Fall as Health Care Slumps Ahead of Presidential Debate
Sep 26 / TheStreet.com - Paid Partner Content
Troubles for Deutsche Bank, Wells Fargo Drag Down Wall Street
Sep 29 / TheStreet.com - Paid Partner Content
Can You Guess Which Big Pharma Has Raised Its Drug Prices 5 Times Since June 2014?
Sep 26 / MotleyFool.com - Paid Partner Content
The Highest-Yielding Drug Stocks
Sep 29 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Stock Falls, Ends Plan to Split Into Two Companies
Sep 26 / TheStreet.com - Paid Partner Content
Dow 30 Stock Roundup: Nike Earnings Impress, Boeing Wins $8B Saudi Order
Sep 29 / Zacks.com - Paid Partner Content
Stock Futures Fall With Clinton-Trump Showdown Looming
Sep 26 / TheStreet.com - Paid Partner Content
7 Healthcare Stocks in Focus on World Heart Day
Sep 29 / Zacks.com - Paid Partner Content
The 5 Highest Dividend Payout Ratios on the Dow
Sep 23 / MotleyFool.com - Paid Partner Content
How Oncology Could Move the Needle for Johnson & Johnson's Stock
Sep 29 / MotleyFool.com - Paid Partner Content
Dow 30 Stock Roundup: Microsoft Rewards Shareholders; GE Wins $1.9B Nuclear Power Con...
Sep 23 / Zacks.com - Paid Partner Content
Why Exelixis, Inc. Got Hammered Today
Sep 28 / MotleyFool.com - Paid Partner Content
Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study
Sep 23 / Zacks.com - Paid Partner Content
Battle of the Pharmaceutical Bigwigs: GlaxoSmithKline vs. Pfizer
Sep 28 / TheStreet.com - Paid Partner Content
Better Buy: Pfizer Inc. vs. Johnson & Johnson
Sep 23 / MotleyFool.com - Paid Partner Content
Opko Health Has Big News on Deck
Sep 27 / MotleyFool.com - Paid Partner Content
Incoming GSK chief faces challenge to maintain momentum
Sep 20 / FT.com - Paid Partner Content
What Gives With Biosimilars?
Sep 27 / MotleyFool.com - Paid Partner Content
Big pharma targets drug-resistant superbugs
Sep 20 / FT.com - Paid Partner Content
Eli Lilly Stock Upgraded: What You Need to Know
Sep 27 / MotleyFool.com - Paid Partner Content
Meet Big Pharma's new female CEO
Sep 20 / CNNMoney.com
Pfizer (PFE) to Stay Together as a Single Company After All
Sep 27 / Zacks.com - Paid Partner Content
Pfizer (PFE) Breast Cancer Drug Ibrance Wins CHMP Backing
Sep 20 / Zacks.com - Paid Partner Content
Is This Pfizer's Next Mega-Blockbuster Cancer Drug?
Sep 27 / MotleyFool.com - Paid Partner Content
Is This New Market the Biggest Investment Idea of the Decade?
Sep 17 / MotleyFool.com - Paid Partner Content
Frontrunning: September 27
Sep 27 / Investing Channel - Paid Partner Content
Takeda earmarks $15bn for US pharma acquisitions
Sep 13 / FT.com - Paid Partner Content
Pfizer's Latest Immunotherapy Deal Could Be Great News for This Tiny Company
Sep 27 / MotleyFool.com - Paid Partner Content
CEO of Botox maker vows to limit price hikes
Sep 07 / CNNMoney.com
Presidential Debate a Factor for the Market This Week
Sep 26 / GuruFocus News - Paid Partner Content
Apple and state aid: the end of the affair
Sep 02 / FT.com - Paid Partner Content
Regeneron, Sanofi Skin Disease Drug Under Priority Review
Sep 26 / Zacks.com - Paid Partner Content
Why the people of this Irish city love Apple
Sep 01 / CNNMoney.com